RxDoctor Payments Data

Nicole Nelson, APRN

Critical Care Medicine · El Paso, TXNPI 1306563770

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Medtronic at 29.8% of the total.

$653in general payments, 2019–2025

Across 20 payments — averaging $32.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$195
  • Inspire Medical Systems, Inc.$123
  • Lexicon Pharmaceuticals, Inc.$88
  • Irhythm Technologies, Inc.$51
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$34
  • Bayer$33
  • plus $130 from 5 others

What the payments were for

  • Food & beverage$653100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$653 in reported general payments places this provider in the 55th percentile of 507 critical care medicine providers in Texas.

See all critical care medicine providers in Texas →

Medicare billing

Part B allowed, 2024
$3,431
Medicare patients
18
Services billed
40

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Torsemide13$517
Furosemide12$15

Paid to pharmacies, not to this prescriber.

Other critical care medicine in El Paso

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →